Bavarian Nordic A/S is a Danish biotechnology company specializing in the research, development, manufacturing, and commercialization of innovative vaccines based on viral vector technologies. Headqua... Bavarian Nordic A/S is a Danish biotechnology company specializing in the research, development, manufacturing, and commercialization of innovative vaccines based on viral vector technologies. Headquartered in Hellerup, Denmark, with manufacturing facilities in Denmark and Switzerland, and R&D sites in Germany plus offices across North America and Europe, it leverages proprietary platforms like MVA-BN, a non-replicating Modified Vaccinia Ankara vector designed for safety and efficacy. The company markets approved vaccines including Jynneos/Imvanex/Imvamune for smallpox and mpox, Rabipur/RabAvert for rabies, Encepur for tick-borne encephalitis, Mvabea as part of an Ebola regimen, Vivotif for typhoid, Vaxchora for cholera, and the recently approved Vimkunya for chikungunya. Bavarian Nordic plays a critical role in global public health, supplying vaccines to government stockpiles, combating outbreaks like mpox and Ebola, and expanding into travel health and biodefense, while advancing a pipeline targeting equine encephalitis and other infectious diseases.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Financial Fundamentals data not yet covered for Bavarian Nordic

We have not yet reviewed Bavarian Nordic's disclosures for Financial Fundamentals data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Bavarian Nordic's data?

Start your 30-day free trial to request a data review for Bavarian Nordic.

Start Free Trial

Legal Center Contact Us